GSK3B and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), downregulation of PFN2 reduced phosphorylation/expression of AKT, GSK-3β, and β-catenin, leading to reduced invasion and metastasis [24].